骨成長刺激装置：パイプライン製品の分析

当レポートでは、世界各国の企業・医療機関などで開発中の骨成長刺激装置のパイプライン製品情報について分析し、治験／製品開発の全体的な進行状況や、段階別・地域別・分野別の詳細動向、企業別・製品別の詳細情報 (治験の進行段階、開始／終了時期、認証見通しなど)、昨今の製品開発・資本取引の動きなどを盛り込んでお届けいたします。

第1章 目次

第2章 イントロダクション

• 骨成長刺激装置の概要

第3章 開発中の製品

• パイプライン製品：開発段階別
• パイプライン製品：地域別
• パイプライン製品：規制経路別
• パイプライン製品：認証時期別 (推定)
• 現在進行中の治験

第4章 骨成長刺激装置：開発中のパイプライン製品 (企業別)

• 骨成長刺激装置の開発企業：開発段階別のパイプライン製品
• 骨成長刺激装置：開発段階別のパイプライン製品

第5章 骨成長刺激装置の開発企業・製品の概要

第6章 骨成長刺激装置：昨今の市場動向

第7章 付録

図表一覧

List of Tables

• Table 1: Bone Growth Stimulators - Pipeline Products by Stage of Development 9
• Table 2: Bone Growth Stimulators - Pipeline Products by Segment 10
• Table 3: Bone Growth Stimulators - Pipeline Products by Territory 11
• Table 4: Bone Growth Stimulators - Pipeline Products by Regulatory Path 12
• Table 5: Bone Growth Stimulators - Pipeline Products by Estimated Approval Date 13
• Table 6: Bone Growth Stimulators - Ongoing Clinical Trials 14
• Table 7: Bone Growth Stimulators Companies - Pipeline Products by Stage of Development 15
• Table 8: Bone Growth Stimulators - Pipeline Products by Stage of Development 16
• Table 9: Bionext Biotech Products Ltd. Pipeline Products & Ongoing Clinical Trials Overview 17
• Table 10: Orthonext - Product Status 17
• Table 11: Orthonext - Product Description 17
• Table 12: Centro de Investigacion Biomedica en Red en Bioingenieria Biomateriales y Nanomedicina Pipeline Products & Ongoing Clinical Trials Overview 18
• Table 13: Bioactive Glass Scaffolds - Product Status 18
• Table 14: Bioactive Glass Scaffolds - Product Description 18
• Table 15: Curative Biosciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview 19
• Table 16: Nurture BSP - Product Status 19
• Table 17: Nurture BSP - Product Description 19
• Table 18: Osteoconductive Scaffold - Product Status 20
• Table 19: Osteoconductive Scaffold - Product Description 20
• Table 20: DJO Global Inc Pipeline Products & Ongoing Clinical Trials Overview 21
• Table 21: CMF OL1000 - Fresh Ankle Fracture - Product Status 21
• Table 22: CMF OL1000 - Fresh Ankle Fracture - Product Description 21
• Table 23: DJO Global Inc - Ongoing Clinical Trials Overview 22
• Table 24: CMF OL1000 - Fresh Ankle Fracture - Prospective, Randomized, Double-blinded, Controlled Multi-center Clinical Trial Evaluating the Use of Non-invasive CMF Bone Stimulation as Adjunct to Surgical Treatment of Ankle Fractures 23
• Table 25: GreenBone Ortho srl Pipeline Products & Ongoing Clinical Trials Overview 24
• Table 26: GreenBone Implant - Product Status 24
• Table 27: GreenBone Implant - Product Description 24
• Table 28: GreenBone Ortho srl - Ongoing Clinical Trials Overview 25
• Table 29: GreenBone Implant - A Pre-market Multicenter National Open Label Single Arm Study to Evaluate the Safety and Performance of a Class III Medical Device (Greenbone Implant) for Iliac Crest Reconstruction Following Bone Graft Harvesting for Pelvic Fusion 26
• Table 30: GreenBone Implant - A Pre-market, Multi-center, International, Open-label, Single-arm Study to Evaluate the Safety and Performance of a Class III Medical Device (GreenBone Implant) for Surgical Repair of Long Bone Defects 26
• Table 31: Inion Oy Pipeline Products & Ongoing Clinical Trials Overview 27
• Table 32: Inion OptimaPLUS - Product Status 27
• Table 33: Inion OptimaPLUS - Product Description 27
• Table 34: Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 28
• Table 35: 3D-printed Bone Extracellular Matrix Scaffold - Product Status 28
• Table 36: 3D-printed Bone Extracellular Matrix Scaffold - Product Description 28
• Table 37: KeraCure, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 29
• Table 38: KeraPac - Bone Regeneration - Product Status 29
• Table 39: KeraPac - Bone Regeneration - Product Description 29
• Table 40: Lattice Biologics Ltd Pipeline Products & Ongoing Clinical Trials Overview 30
• Table 41: Bone Scaffold + ECM - Product Status 30
• Table 42: Bone Scaffold + ECM - Product Description 30
• Table 43: NDSU Research Foundation Pipeline Products & Ongoing Clinical Trials Overview 31
• Table 44: Bone Scaffold - Product Status 31
• Table 45: Bone Scaffold - Product Description 31
• Table 46: Oklahoma State University Pipeline Products & Ongoing Clinical Trials Overview 32
• Table 47: Bone Repair Scaffold - Product Status 32
• Table 48: Bone Repair Scaffold - Product Description 32
• Table 49: Orthocell Ltd Pipeline Products & Ongoing Clinical Trials Overview 33
• Table 50: CelGro SMRT Graft - Bone Repair - Product Status 33
• Table 51: CelGro SMRT Graft - Bone Repair - Product Description 33
• Table 52: Orthofix Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 34
• Table 53: Cervical-Stim Osteogenesis Stimulator - Odontoid Fractures - Product Status 34
• Table 54: Cervical-Stim Osteogenesis Stimulator - Odontoid Fractures - Product Description 35
• Table 55: Physio-Stim Osteogenesis Stimulator - Osteoarthritis - Product Status 35
• Table 56: Physio-Stim Osteogenesis Stimulator - Osteoarthritis - Product Description 35
• Table 57: RCStim Device - Product Status 36
• Table 58: RCStim Device - Product Description 36
• Table 59: Orthofix Medical Inc - Ongoing Clinical Trials Overview 37
• Table 60: Cervical-Stim Osteogenesis Stimulator - Odontoid Fractures - A Multi-center, Open-label, Prospective Study of CervicalStim Device as Adjunctive Care Following Cervical Fusion 38
• Table 61: Cervical-Stim Osteogenesis Stimulator - Odontoid Fractures - Safety and Efficacy of Pulsed Electromagnetic Fields (Cervical-Stim) as an Adjunct to Enhance Union in Conservatively Treated Type II Fractures of the Odontoid Process 38
• Table 62: Physio-Stim Osteogenesis Stimulator - Osteoarthritis - A Prospective, Randomized, Double-blind, Placebo Controlled Study to Evaluate Efficacy and Safety of an Active Pulsed Electromagnetic Field for the Treatment of Osteoarthritis of the Knee 39
• Table 63: RCStim Device - Prospective, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Safety and Efficacy of Pulsed Electromagnetic Field (PEMF) Therapy as an Adjunctive Treatment to Surgical Repair of Full Thickness Rotator Cuff Tears 40
• Table 64: OsteoGenix Incorporated (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 41
• Table 65: Bone Anabolic Agent - Product Status 41
• Table 66: Bone Anabolic Agent - Product Description 41
• Table 67: REGENECURE Ltd Pipeline Products & Ongoing Clinical Trials Overview 42
• Table 68: Regenecure AMCA GBR Bone Membrane Implant - Product Status 42
• Table 69: Regenecure AMCA GBR Bone Membrane Implant - Product Description 42
• Table 70: Texas A&M University Pipeline Products & Ongoing Clinical Trials Overview 43
• Table 71: Bioactive Foam Based Moldable Scaffold - Product Status 43
• Table 72: Bioactive Foam Based Moldable Scaffold - Product Description 43
• Table 73: Tornier Inc Pipeline Products & Ongoing Clinical Trials Overview 44
• Table 74: Soft Tissue Graft - Product Status 44
• Table 75: Soft Tissue Graft - Product Description 44
• Table 76: Universiti Putra Malaysia Pipeline Products & Ongoing Clinical Trials Overview 45
• Table 77: Nanocomposite Bone Scaffold - Product Status 45
• Table 78: Nanocomposite Bone Scaffold - Product Description 45
• Table 79: University of Florida Pipeline Products & Ongoing Clinical Trials Overview 46
• Table 80: Bone Tissue Scaffold - Product Status 46

List of Figures

• Figure 1: Bone Growth Stimulators - Pipeline Products by Stage of Development 9
• Figure 2: Bone Growth Stimulators - Pipeline Products by Segment 10
• Figure 3: Bone Growth Stimulators - Pipeline Products by Territory 11
• Figure 4: Bone Growth Stimulators - Pipeline Products by Regulatory Path 12
• Figure 5: Bone Growth Stimulators - Pipeline Products by Estimated Approval Date 13
• Figure 6: Bone Growth Stimulators - Ongoing Clinical Trials 14

GlobalData's Medical Devices sector report, "Bone Growth Stimulators - Medical Devices Pipeline Assessment, 2019" provides an overview of Bone Growth Stimulators currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Bone Growth Stimulators pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

• Extensive coverage of the Bone Growth Stimulators under development
• The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
• The report reviews the major players involved in the development of Bone Growth Stimulators and list all their pipeline projects
• The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
• The report provides key clinical trial data of ongoing trials specific to pipeline products
• Recent developments in the segment / industry

Reasons to buy

The report enables you to -

• Formulate significant competitor information, analysis, and insights to improve R&D strategies
• Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
• Identify and understand important and diverse types of Bone Growth Stimulators under development
• Develop market-entry and market expansion strategies
• Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
• In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1. Table of Contents

• 1.1 List of Tables
• 1.2 List of Figures

2 Introduction

• 2.1 Bone Growth Stimulators Overview

3 Products under Development

• 3.1 Bone Growth Stimulators - Pipeline Products by Stage of Development
• 3.2 Bone Growth Stimulators - Pipeline Products by Segment
• 3.3 Bone Growth Stimulators - Pipeline Products by Territory
• 3.4 Bone Growth Stimulators - Pipeline Products by Regulatory Path
• 3.5 Bone Growth Stimulators - Pipeline Products by Estimated Approval Date
• 3.6 Bone Growth Stimulators - Ongoing Clinical Trials

4 Bone Growth Stimulators - Pipeline Products under Development by Companies

• 4.1 Bone Growth Stimulators Companies - Pipeline Products by Stage of Development
• 4.2 Bone Growth Stimulators - Pipeline Products by Stage of Development

5 Bone Growth Stimulators Companies and Product Overview

• 5.1 Bionext Biotech Products Ltd. Company Overview
• 5.2 Centro de Investigacion Biomedica en Red en Bioingenieria Biomateriales y Nanomedicina Company Overview
• 5.3 Curative Biosciences, Inc. Company Overview
• 5.4 DJO Global Inc Company Overview
• 5.5 GreenBone Ortho srl Company Overview
• 5.6 Inion Oy Company Overview
• 5.7 Johns Hopkins University Company Overview
• 5.8 KeraCure, Inc. (Inactive) Company Overview
• 5.9 Lattice Biologics Ltd Company Overview
• 5.10 NDSU Research Foundation Company Overview
• 5.11 Oklahoma State University Company Overview
• 5.12 Orthocell Ltd Company Overview
• 5.13 Orthofix Medical Inc Company Overview
• 5.14 OsteoGenix Incorporated (Inactive) Company Overview
• 5.15 REGENECURE Ltd Company Overview
• 5.16 Texas A&M University Company Overview
• 5.17 Tornier Inc Company Overview
• 5.18 Universiti Putra Malaysia Company Overview
• 5.19 University of Florida Company Overview
• 5.20 University of Nottingham Company Overview
• 5.21 ZetaGen Therapeutics Inc Company Overview
• 5.22 Zimmer Biomet Holdings Inc Company Overview

6 Bone Growth Stimulators- Recent Developments

• 6.1 Aug 28, 2019: Medtronic announces planned leadership succession
• 6.2 Aug 20, 2019: Kuros Biosciences reports results for first half 2019
• 6.3 Aug 20, 2019: Medtronic reports first quarter financial results for 2019
• 6.4 Aug 12, 2019: Stryker announces commercial structure realignment
• 6.5 Aug 01, 2019: Globus Medical reports second quarter 2019 results
• 6.6 Aug 01, 2019: Integer Holdings reports second quarter 2019 results
• 6.7 Jul 26, 2019: Zimmer Biomet announces second quarter 2019 financial results
• 6.8 Jul 25, 2019: Spineway : Strengthening corporate governance appointment of two new board members
• 6.9 Jul 25, 2019: Stryker reports second quarter 2019 operating results
• 6.10 Jul 24, 2019: Former Medtronic Executive Sean Ginney named VP of Sales at Current Health
• 6.11 Jul 24, 2019: Kuros announces Gerhard Ries is stepping down as Board member
• 6.12 Jul 24, 2019: Anika reports second quarter 2019 financial results
• 6.13 Jul 11, 2019: Spineway : Half-year revenue of €2.6M
• 6.14 Jul 08, 2019: Anika appoints James Loerop as executive vice president of business development and strategic planning
• 6.15 Jun 27, 2019: Globus Medical appoints Keith Pfeil as Senior Vice President and CFO
• 6.16 Jun 20, 2019: Collplant announces corporate name change to Collplant Biotechnologies to better reflect its business
• 6.17 Jun 19, 2019: Zimmer Biomet announces chief financial officer transition plan
• 6.18 Jun 14, 2019: Stryker to invest €200m in RD&I projects in Ireland
• 6.19 May 30, 2019: CollPlant reports first quarter 2019 financial results and provides business update
• 6.20 May 23, 2019: Medtronic announces fiscal year and fourth quarter 2019 financial results
• 6.21 May 22, 2019: CollPlant Launches New HQ and R&D Center in Israel
• 6.22 May 02, 2019: Integer Holdings reports first quarter 2019 results
• 6.23 May 02, 2019: Globus Medical announces first quarter 2019 results
• 6.24 May 02, 2019: Globus Medical reports first quarter 2019 results
• 6.25 May 02, 2019: Anika reports first quarter 2019 financial results
• 6.26 Apr 30, 2019: Kuros Biosciences to propose re-appointment of chairman and board members at Annual General Meeting
• 6.27 Apr 30, 2019: Anika Therapeutics names Stephen Goldy as vice president of U.S. Sales
• 6.28 Apr 29, 2019: Spineway: 2018 annual results
• 6.29 Apr 26, 2019: Zimmer Biomet announces first quarter 2019 financial results
• 6.30 Apr 23, 2019: Stryker announces first quarter 2019 operating results
• 6.31 Apr 12, 2019: Kuros Biosciences reports results for the full year 2018
• 6.32 Apr 10, 2019: Biologica Technologies exhibits latest foot and ankle arthrodesis data for ProteiOS at The Midwest Podiatry Conference
• 6.33 Apr 01, 2019: CollPlant Reports Fourth Quarter and Year End 2018 Financial Results and Provides Business Update
• 6.34 Mar 29, 2019: PolarityTE announces Richard Hague, formerly from Sanofi, Genzyme and recently Anika Therapeutics as Chief Operating Officer
• 6.35 Mar 27, 2019: Stryker announces new Vice President, chief legal officer
• 6.36 Mar 25, 2019: Medtronic launches Medtech Innovation Accelerator in Shanghai
• 6.37 Mar 18, 2019: Anika Therapeutics names Robert Richard as Vice President of research and development
• 6.38 Mar 14, 2019: Medtronic names Andrea J. Goldsmith as a new director
• 6.39 Feb 21, 2019: Globus Medical reports full year and fourth quarter 2018 Results
• 6.40 Feb 21, 2019: Integer Holdings reports results for fourth quarter and full year 2018
• 6.41 Feb 21, 2019: Anika reports fourth quarter and full year 2018 financial results
• 6.42 Feb 19, 2019: Medtronic reports third quarter financial results
• 6.43 Feb 04, 2019: CollPlant names Jonathan M.N. Rigby as Chairman of the Board
• 6.44 Feb 01, 2019: Zimmer Biomet announces fourth quarter and full-year 2018 financial results
• 6.45 Jan 29, 2019: Stryker reports 2018 results and 2019 outlook
• 6.46 Jan 16, 2019: Spineway: 2018 revenue of €6.5M
• 6.47 Jan 09, 2019: Medtronic Foundation Recognizes 12 Bakken Invitation Honorees for Driving Positive Change in Healthcare
• 6.48 Jan 08, 2019: Globus Medical reports preliminary record fourth quarter and full year sales results
• 6.49 Dec 10, 2018: Medtronic named one of America's Best Corporate Citizens in 2018 by Forbes Magazine
• 6.50 Nov 26, 2018: Osiris Therapeutics names Samson Tom, PhD, MBA to serve as President and Chief Executive Officer
• 6.51 Nov 20, 2018: Medtronic reports financial results of second quarter of fiscal year 2019
• 6.52 Nov 20, 2018: Medtronic Reports Second Quarter Financial Results
• 6.53 Nov 08, 2018: Globus Medical reports third quarter 2018 results
• 6.54 Nov 08, 2018: Medtronic delivers significant progress on global corporate citizenship efforts
• 6.55 Nov 07, 2018: Osiris Therapeutics reports third quarter 2018 results
• 6.56 Nov 01, 2018: Integer Holdings Reports Third Quarter 2018 Results
• 6.57 Oct 31, 2018: Zimmer Biomet appoints Ivan Tornos as Group President, Orthopedics
• 6.58 Oct 26, 2018: Zimmer Biomet announces third quarter 2018 financial results
• 6.59 Oct 25, 2018: Susan M. Stalnecker named to Bioventus Board of Managers
• 6.60 Oct 25, 2018: Stryker reports third quarter 2018 operating results
• 6.61 Oct 24, 2018: Anika Therapeutics announces Third Quarter 2018 Financial Results
• 6.62 Oct 24, 2018: Anika Therapeutics names Susan Vogt as Board Director
• 6.63 Oct 13, 2018: Johnson Fistel Announces Investigations of Zimmer Biomet Holdings and Acadia Healthcare Company
• 6.64 Oct 08, 2018: Stryker names Meenakshi Nevatia as New MD for India
• 6.65 Oct 04, 2018: CelGro used as artificial periosteum repairs bone
• 6.66 Oct 03, 2018: Osiris Therapeutics announces peer-reviewed publication demonstrating that lyopreservation method developed for living tissues is an alternative to cryopreservation
• 6.67 Sep 29, 2018: Collplant reports third quarter 2018 financial results and provides business update

7 Appendix

• 7.1 Methodology
• 7.2 About GlobalData
• 7.3 Contact Us
• 7.4 Disclaimer